
Moirai Biodesign
Engineering of RNA-based therapies and diagnostics.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | Seed | ||
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | - | 154 % | 169 % | (94 %) | 36 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | - | 4 % | (7 %) | 73 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | - | 4 % | (7 %) | 64 % | (189 %) | (165 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Moirai Biodesign is a pioneering company at the intersection of synthetic biology and computational biology, focusing on RNA design for biomedicine. The company aims to revolutionize healthcare by providing rapid, accurate, and affordable diagnostic methods. Their primary product is a diagnostics platform that uses programmable RNA biosensors to detect specific RNA targets. This technology offers fast results within an hour, high accuracy, and ease of use with standard laboratory equipment, making it accessible and cost-effective for healthcare professionals.
Moirai Biodesign serves a range of clients in the healthcare sector, including hospitals, clinics, and research institutions. The company operates in the clinical diagnostics market, which is a critical segment of the broader healthcare industry. Their business model revolves around selling their diagnostic platform and offering tailored consultancy services for RNA design. They generate revenue through the sale of their diagnostic kits and software, as well as through consultancy fees.
The company's innovative approach leverages their expertise in engineering biological systems and controlling gene expression. This allows them to create programmable regulatory systems that can be customized to meet specific diagnostic needs. By focusing on RNA design, Moirai Biodesign is positioned to address key challenges in healthcare diagnostics, offering solutions that are both effective and economically viable.
In summary, Moirai Biodesign is a cutting-edge biotech company dedicated to improving healthcare diagnostics through advanced RNA technology. Their focus on rapid, accurate, and affordable solutions makes them a valuable player in the clinical diagnostics market.
Keywords: RNA design, synthetic biology, computational biology, diagnostics, healthcare, biomedicine, biosensors, gene expression, clinical diagnostics, biotechnology.